Randomized Suicide Prevention Trial Using ASSIP and ACT in Suicide Attempters

Launched by ARDAKAN UNIVERSITY · Aug 18, 2025

Keywords

ClinConnect Summary

This clinical trial is studying two different types of psychological treatments to help people who have recently tried to take their own life. The goal is to find out which treatment—called ASSIP (Attempted Suicide Short Intervention Program) or ACT (Acceptance and Commitment Therapy)—works better to reduce thoughts about suicide and feelings of deep mental pain. Both treatments will be compared to the usual care that patients receive, to see if adding these therapies can make a difference.

People who are 18 years or older, can read and write, and have attempted suicide within the last four months may be eligible to join. Participants will be divided into three groups: one will receive ASSIP plus usual care, another will get ACT plus usual care, and the last group will continue with usual care only. The study will check how participants are doing before treatment, right after, and at a later follow-up using simple questionnaires about suicidal thoughts and emotional pain. This research aims to help doctors and therapists better support people at risk and improve future suicide prevention efforts.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Being 18 years of age or older
• • Having the ability to read and write
• • Providing informed consent to participate in the study
• • Having at least one suicide attempt in the past 4 months
• Exclusion Criteria:
• • Having a severe psychiatric or physical illness that interferes with the treatment process
• • Receiving concurrent structured psychological interventions (other than TAU) that may interfere with the study's treatment process.
• • Lack of informed consent to participate in the study
• • Substance abuse based on DSM-5 criteria